AEMMX
Price
$19.80
Change
+$0.74 (+3.88%)
Updated
Jun 18 closing price
Net Assets
2.06B
VEMIX
Price
$38.34
Change
+$0.52 (+1.37%)
Updated
Jun 18 closing price
Net Assets
162.82B
Interact to see
Advertisement

AEMMX vs VEMIX

AEMMX vs VEMIX Comparison Chart in %
View a ticker or compare two or three
VS
AEMMX vs. VEMIX commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEMMX is a Buy and VEMIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 163B vs. AEMMX (2.06B). VEMIX pays higher dividends than AEMMX: VEMIX (2.42) vs AEMMX (0.70). AEMMX was incepted earlier than VEMIX: AEMMX (27 years) vs VEMIX (26 years). AEMMX (1.51) is less costly to investors than VEMIX (0.06). AEMMX is a more actively managed with annual turnover of: 58.00 vs. VEMIX (6.00). AEMMX has a lower initial minimum investment than VEMIX: AEMMX (2500) vs VEMIX (5000000). AEMMX annual gain was more profitable for investors over the last year : 71.59 vs. VEMIX (28.48). AEMMX return over 5 years is better than : 44.32 vs. VEMIX (26.22).
AEMMXVEMIXAEMMX / VEMIX
Total Expense Ratio1.510.062,517%
Annual Report Gross Expense Ratio1.510.062,517%
Fund Existence27 years26 years-
Gain YTD38.46213.118293%
Front Load6%N/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.06B163B1%
Annual Yield % from dividends0.702.4229%
Returns for 1 year71.5928.48251%
Returns for 3 years104.5248.90214%
Returns for 5 years44.3226.22169%
Returns for 10 years170.16110.64154%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEOHX20.480.38
+1.89%
Voya Large Cap Growth Port I
TRACX21.990.32
+1.48%
PGIM Quant Solutions Small-Cap Val C
MSCMX16.830.16
+0.96%
Morgan Stanley Insight C
OINCX26.150.06
+0.23%
JPMorgan Equity Income C
RYCFX46.850.03
+0.06%
Rydex Biotechnology C